Skip to main content
Other official information and services:
www.belgium.be
en
nl
fr
de
en
Navigation>
Search
Receive news
Contact
Jobs
Sitemap
Data processing
search
Publications
All reports
Support tools for medical consultation
COVID-19 Contributions
Health Systems in Transition (HiT)
Annual reports
Workprogramme
Ongoing and planned projects
Submit a topic
Tenders
KCE Trials
Calls
Resources
News and upcoming events
Collaboration
Funded trials
About us
COVID-19 Contributions
About us
What is the KCE ?
International collaboration
Our methods and procedures
Press release
Publications
Long COVID: Pathophysiology – epidemiology and patient needs
Do innovative medicines against cancer always have a real added value?
An EQ-5D-5L value set for Belgium – How to value health-related quality of life?
Assessing the sustainability of the Belgian health system using projections
Patient involvement in policy research at KCE: process note
search
Long COVID: Pathophysiology – epidemiology and patient need
European HTA agencies launch the Heads of Agencies Group (HAG)
Vaccination coverage in Belgian health care institutions
2021/September- Latest news from KCE Trials
Do innovative medicines against cancer always have a real added value?
1
/
Workprogramme
search
Proposal for KCE’s annual program
Submit a topic
Ongoing and planned projects
Tenders
KCE Trials
Funded trials
Calls
Resources
Collaboration
News and upcoming events
FOLLOW US
Published on:
2021/10/27
